Financial Press Releases

  • 13/12/2019 ore 16:53
    Friulchem approves the transaction with related party
  • 28/11/2019 ore 17:55
    Friulchem approves the framework resolution concerning the contract for the supply of raw materials with Evultis
  • 15/10/2019 ore 07:15
    Friulchem obtains authorization for the marketing in South Africa of an antibiotic for human use with a wide spectrum of action for serious infections

    Friulchem S.p.A. (AIM: FCM), announces that it has obtained, after a "registration process" of over 5 years, the authorization for the marketing in South Africa of a broad-spectrum antibiotic for human use (injectable betalactam belonging to the class of carbapenems for the treatment of serious infections) and to have entered into an agreement with a leading multinational pharmaceutical company - world leader in the distribution of generic drugs - for exclusive distribution in South Africa.

  • 27/09/2019 ore 18:47
    Friulchem continues its internationalization process with the establishment of Friulchem USA Inc.

    Friulchem S.p.A. (AIM: FCM) communicates the constitution of the Friulchem USA Inc. company. The newly company will be active in the marketing and distribution of feed supplement or non-pharmaceutical products for the North American veterinary sector.

  • 27/09/2019 ore 09:30
    CEO at the 2019 semi-annual report

    Disma Giovanni Mazzola, CEO of Friulchem S.p.A. (AIM: FCM) commented on the 2019 half-year figures

  • 26/09/2019 ore 17:55
    Friulchem: the half-year report as of June 30, 2019 approved
  • 29/07/2019 ore 17:58
    SIGNIFICANT SHAREHOLDERS (Available only in Italian)
  • 25/07/2019 ore 18:01
    CORPORATE EVENTS CALENDAR 2019 (Available only in Italian)
  • 23/07/2019 ore 18:37
    NOTIFIED TO CONSOB THE KID - "KEY INFORMATION DOCUMENT" CONCERNING THE "WARRANT FRIULCHEM 2019-2022"
  • 23/07/2019 ore 16:25
    FRIULCHEM S.p.A. ADMITTED TO TRADING ON THE AIM ITALIA MARKET